Streetbeat News

Earnings

THC

Tenet Healthcare has raised its FY24 revenue outlook to $20B-$20.40B, up from $19.90B-$20.30B, surpassing the $20.37B estimate. Adjusted EPS is now expected to be $8.37-$9.41, significantly higher than the $6.11 estimate. This updated outlook follows the sale of nine hospitals in South Carolina and California.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 10:53 am

EAT

Brinker International has increased its FY24 adjusted EPS forecast from $3.45-$3.70 to $3.80-$4.00, surpassing the estimated $3.69. Additionally, the company adjusted its total revenue outlook from $4.30B-$4.35B to a narrower range of $4.33B-$4.35B, closely aligning with the estimated $4.338B.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 10:52 am

PLL

Piedmont Lithium announced the shipment of approximately 15,500 dry metric tons (dmt) of spodumene concentrate in the first quarter of 2024.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 10:51 am

LLY

Eli Lilly has raised its revenue forecast for 2024 to $42.4 billion to $43.6 billion, up from the previous guidance of $40.4 billion to $41.6 billion, surpassing the consensus estimate of $41.36 billion.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 10:51 am

LLY

Eli Lilly has updated its 2024 adjusted EPS guidance to $13.50-$14.00, significantly higher than its previous forecast of $12.20-$12.70 and above the consensus estimate of $12.46.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 10:50 am

THC

Tenet Healthcare (THC) provided its Q2 and full year 2024 outlook, projecting revenues between $4.9B-$5.1B for Q2, surpassing the $4.98B estimate. Adjusted EPS for Q2 is expected to be between $1.58-$1.98, exceeding the $1.41 estimate. The full year 2024 outlook includes net operating revenues of $20,000 to $20,400 million and adjusted EBITDA of $3,500 to $3,700 million. These projections follow the sale of nine hospitals in South Carolina and California.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 10:50 am

LLY

Eli Lilly's stock price increased following the company's announcement of raised revenue guidance for the fiscal year 2024.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 10:49 am

MPLX

MPLX reported Q1 sales of $2.85 billion, missing the analyst consensus estimate of $2.90 billion by 1.83%. This represents a 4.90% increase over the same period last year.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 10:48 am

EAT

Brinker International reported a 3.3% increase in Q3 comparable restaurant sales, with Chili's at 3.5% and Maggiano's at 1.7%.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 10:48 am

THC

Tenet Healthcare (NYSE:THC) reported Q1 2024 adjusted EPS of $3.22, surpassing the $1.43 estimate, and sales of $5.368B, exceeding the $5.152B estimate. This represents a significant increase in earnings and sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 10:47 am